Prokidney (PROK) EBT (2021 - 2026)

Prokidney (PROK) has 6 years of EBT data on file, last reported at -$42.6 million in Q1 2026.

• On a quarterly basis, EBT fell 14.08% year-over-year to -$42.6 million in Q1 2026; TTM through Mar 2026 was -$156.5 million, a 5.78% increase from a year earlier, with the FY2025 full-year figure at -$151.2 million, up 7.77% from the prior year.
• EBT for Q1 2026 stood at -$42.6 million, roughly flat from -$42.4 million in the prior quarter.
• Over the last five years, EBT for PROK reached as high as -$18.9 million in Q4 2023 and fell as low as -$66.5 million in Q1 2022.
• Historically, EBT has averaged -$37.3 million across 5 years, with a median of -$36.1 million in 2025.
• Across the five-year window, EBT sank 392538.5% in 2022 and surged 46.47% in 2023, its largest moves.
• Year by year, EBT stood at -$25.8 million in 2022, then advanced by 26.72% to -$18.9 million in 2023, then sank by 147.09% to -$46.8 million in 2024, then rose by 9.29% to -$42.4 million in 2025, then retreated by 0.43% to -$42.6 million in 2026.
• Per Business Quant data, the three most recent EBT figures were -$42.6 million in Q1 2026, -$42.4 million in Q4 2025, and -$35.3 million in Q3 2025.